
BioNTech Stock Rises After Earnings. Pfizer’s Vaccine Partners Is Battling a Covid Downturn.
BioNTech, the German pharmaceutical company that partnered with Pfizer to create a Covid-19 vaccine, posted a surprise earnings beat. For the third quarter, earnings